Back to search
FDAFDA · Food and drugs·Recall number D-0293-2026

Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.

Published January 28, 2026 · Recall initiated: January 10, 2026

Summary

FDA records drug Class II recall D-0293-2026, published January 28, 2026 and initiated January 10, 2026. Recalling firm: Graviti Pharmaceuticals Private Limited; Status: Ongoing; Reported quantity: 4212 bottles; Lot: Lot# FUB125042G; Exp. 05/13/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance

What to do

Voluntary: Firm initiated · Letter

Get an email if FUROSEMIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FUROSEMIDE
Manufacturer
Graviti Pharmaceuticals Private Limited
Distributor
U.S. Nationwide
UPC
0364980564014
Lot
Lot# FUB125042G; Exp. 05/13/2027
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10. recalled?

Yes. FDA published recall D-0293-2026 on January 28, 2026. Reported hazard: Presence of Foreign Substance

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FUROSEMIDE. UPC: 0364980564014.